Assoc. Prof. PD Dr. Martin ANDREAS, MBA, PhD, MEBCTS

Work address
Medical University of Vienna
Department of Cardiac Surgery
Waehringer Guertel 18-20
1090 Vienna, Austria

Phone: +43 (0)1 40400 - 52620
Mobile: +43 664 523 5472
E-Mail: martin.andreas@meduniwien.ac.at

Know-how and research interests

• Heart valve disease: Ross procedure, bioprostheses, rapid-deployment valves, adjustable mitral rings, decellularized homografts, aortic valve reconstruction
• Clinical trials applying pharmacological approaches in cardiac surgery: Heme oxygenase - 1 induction, optimal perioperative antibiotic prophylaxis measured by microdialysis, selective endothelin blocker (BQ-123) during CABG surgery
• Biobanking: Heart transplant biobank for detection of rejection and cardiac allograft vasculopathy
• Aneurysms of the thoracic aorta: Defining genetic risk factors for the development of aneurysms
• Ischemia reperfusion injury: Development of a model to detect early effects of therapeutic approaches for ischemia - reperfusion injury in healthy subjects applying functional magnetic resonance imaging.

Research topic (general title)

Heart Valve Disease

Techniques and infrastructure of the research group

• Clinical trials in heart valve surgery
• Hybrid operating room
• Echocardiography
• First-in-Man trial
• Microdialysis in cardiac surgery
• Heart transplant biobank

5 selected publications

• Conduction disturbances following surgical aortic valve replacement with a rapid-deployment bioprosthesis. Coti I, Schukro C, Drevinja F, Haberl T, Kaider A, Kocher A, Laufer G, Andreas M. J Thorac Cardiovasc Surg. 2020 Feb 19:S0022-5223(20)30433-5. doi: 10.1016/j.jtcvs.2020.01.083.
• Electrical stimulation of the greater auricular nerve to reduce postoperative atrial fibrillation. Andreas M, Arzl P, Mitterbauer A, Ballarini NM, Kainz FM, Kocher A, Laufer G, Wolzt M. Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007711. doi: 10.1161/CIRCEP.119.007711. Epub 2019 Oct 10.
• Long-term performance of pulmonary homografts after the Ross procedure: experience up to 25 years. Oeser C, Uyanik-Uenal K, Kocher A, Laufer G, Andreas M. Eur J Cardiothorac Surg. 2019 May 1;55(5):876-884. doi: 10.1093/ejcts/ezy372.
• Intravenous heme arginate induces HO-1 (heme oxygenase-1) in the human heart.
  Andreas M, Oeser C, Kainz FM, Shabanian S, Aref T, Bilban M, Messner B, Heidtmann J, Laufer G, Kocher A, Wolzt M. Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2755-2762. doi: 10.1161/ATVBAHA.118.311832.
• Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial.
• Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T, Angleitner P, Schlöglhofer T, Wiedemann D, Schima H, Laufer G, Zimpfer D. Circ Heart Fail. 2017 May;10(5):e003709. doi: 10.1161/CIRCHEARTFAILURE.116.003709.